Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional

Main|Search|PHGKB



Last Posted: Aug 06, 2018

---

• Genomic biomarkers in prostate cancer.
  Kornberg Zachary et al. Translational andrology and urology 2018 Jun (3) 459-471
• Liquid biopsy approach in the management of prostate cancer.
  Riaz Irbaz Bin et al. Translational research : the journal of laboratory and clinical medicine 2018 May
• Traceback Testing: Increasing Identification and Genetic Counseling of Mutation Carriers through Family-based Outreach (U01 Clinical Trial Optional
  HIH funding announcement, August 2018
• A Review of Molecular Predictors of Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer.
  Degener Stephan et al. Mini reviews in medicinal chemistry 2018 18(13) 1133-1142
• A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: Mutually exclusive, or not?
  Vos Shoko et al. Critical reviews in oncology/hematology 2018 Jul 12729-41
• Application of 21-gene recurrence score results and ASTRO suitability criteria in breast cancer patients treated with intraoperative radiation therapy (IORT).
  Schwartzberg Barbara S et al. American journal of surgery 2018 Jul
• Blood based biomarkers beyond genomics for lung cancer screening.
  Hanash Samir M et al. Translational lung cancer research 2018 Jun 7(3) 327-335
• BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.
  Kowalik Artur et al. PloS one 2018 13(7) e0201086
• Coping Mechanisms, Psychological Distress, and Quality of Life Prior to Cancer Genetic Counseling.
  Di Mattei Valentina E et al. Frontiers in psychology 2018 91218
• Current Tissue Molecular Markers in Colorectal Cancer: A Literature Review.
  Peluso Gaia et al. BioMed research international 2017 20172605628

more